What are the top competitors of HS2.DE in Healthcare sector?

The top competitors of HS2.DE in the Healthcare sector are: Coloplast A/S (CBHD.DE), DENTSPLY SIRONA Inc. (DY2.DE).

Which has better valuations & earnings, HS2.DE or its competitors?

HS2.DE has a market cap of 9.38B and a Dividend Yield of N/A compared to its competitors.

Which stock is more profitable: HS2.DE or its competitors?

HS2.DE has an EPS of $3.23, while CBHD.DE has an EPS of $2.70. So, HS2.DE is more profitable compared to CBHD.DE.

What is HS2.DE stock volatility and risk in terms of investment?

HS2.DE has daily volatility of 0.03% as compared to its competitor CBHD.DE which is 1.48%. HS2.DE is less volatile as compared to competitors and has low risk.

Is HS2.DE stock profitable?

HS2.DE has a Return on Equity (ROE) of 0.11%. So, HS2.DE is more profitable.

What is HS2.DE stock’s 52 weeks high and low?

HS2.DE stock has a 52-week high of ($78.96) and a low of ($58.62).

What was the average volume of HS2.DE stock?

The average volume of HS2.DE is (15.00) in terms of investment.

Henry Schein, Inc. (HS2.DE) Competitors

Henry Schein, Inc. HS2.DE Peers

See (HS2.DE) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Equipment & Services Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

Symbol	Price	Change %	Market Cap	P/E Ratio	EPS	Dividend Yield
HS2.DE	$74.06	+0.11%	9.38B	22.93	$3.23	N/A
CBHD.DE	$85.12	-1.78%	19.29B	31.53	$2.70	+1.68%
DY2.DE	$17.77	+0.54%	3.76B	8.34	$2.13	N/A

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

HS2.DE vs CBHD.DE Comparison

HS2.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HS2.DE stands at 9.38B. In comparison, CBHD.DE has a market cap of 19.29B. Regarding current trading prices, HS2.DE is priced at $74.06, while CBHD.DE trades at $85.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HS2.DE currently has a P/E ratio of 22.93, whereas CBHD.DE's P/E ratio is 31.53. In terms of profitability, HS2.DE's ROE is +0.11%, compared to CBHD.DE's ROE of +0.30%. Regarding short-term risk, HS2.DE is less volatile compared to CBHD.DE. This indicates potentially lower risk in terms of short-term price fluctuations for HS2.DE.

Henry Schein, Inc.